Infant respiratory distress syndrome is also known as neonatal respiratory distress syndrome or hyaline membrane disease. It is caused by developmental insufficiency of surfactant production and structural immaturity in the lungs of the infants. It may be also a genetic problem with the production of surfactant associated proteins.
Infant respiratory distress syndrome is a syndrome in premature infants caused by developmental insufficiency of surfactant production and structural immaturity in the lungs. It can also result from a genetic problem with the production of surfactant associated proteins. The incidence decreases with advancing gestational age, from about 50% in babies born at 26-28 weeks, to about 25% at 30-31 weeks. The syndrome is more frequent in infants of diabetic mothers and in the second born of premature twins.Infant respiratory distress syndrome symptoms include Fast breathing, a fast heart rate, chest wall retractions (recession), expiratory grunting, nasal flaring and blue discoloration of the skin during breathing efforts. The lungs of infants with respiratory distress syndrome are developmentally deficient in a material called surfactant, which helps prevent collapse of the terminal air-spaces (the future site of alveolar development) throughout the normal cycle of inhalation and exhalation.
Related Journals of Infant respiratory distress syndrome
Gynecology Journal, Journal of Healthcare, Pediatric Infectious Journal, Pregnancy and Childhealth Journal, Clinics Mother and Childhealth Journal,Infant Observation,Newborn and Infant Nursing Review,Infants and Young Children.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : March 18, 2019